A new experimental weight loss drug from Amgen — the first in a growing group of drugs aimed at once-a-month injections instead of once a week — helped patients lose up to 20% of their weight in one ...
December S&P 500 E-Mini futures (ESZ24) are down -0.18%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.33% this morning as investors digested Donald Trump’s latest cabinet appointments ...
Jordan welcomed a ceasefire that entered into force Wednesday between Israel and Hezbollah in Lebanon, calling it a critical step towards ending the war between Israel and Hamas in Gaza.
The last remaining asylum seekers being housed on the controversial floating accommodation barge Bibby Stockholm in southern England have left, local authorities said on Wednesday.
Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Amgen (AMGN – Research Report), retaining the price target of $335.00.Don't ...
Goldman Sachs analyst Salveen Richter has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...
Stocktwits on MSN56m
Amgen Stock Slips After More Analyst Criticism On Weight-Loss Drug Data: Retail Eyes ‘Great Buying Opportunity’Shares of Amgen Inc. ($AMGN) edged down 0.3% in premarket trading Wednesday, on course to extend a losing streak to a third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback